1. Selected strains, one shot for three prevention
This product provides one shot three prevention, with the LaSota strain being the preferred choice, combined with highly homologous strains of the prevalent Newcastle disease genotype in China; The preferred H9 subtype avian influenza strain Yt has good homology with current epidemic strains and good cross protection; The adenovirus antigen expressed through genetic engineering technology can comprehensively prevent infections caused by adenovirus.
2. Antigen purification
The ultrafiltration concentration process effectively removes urate salts, lipopolysaccharides, and impurities from the urinary bladder fluid to ensure antigen purity and minimize immune injection stress.
3. Imported adjuvant for more complete absorption
Using original imported high-quality adjuvants, with low viscosity and a viscosity index of 20-40cP (national standard 200cP), it has low immune stress, good fluidity, easy to draw, easy to hit and absorb, and produces antibodies quickly.
4. Advanced technology, minimal immune stress
Using low-temperature emulsification technology, the finished emulsified particles have excellent particle size and a typical normal distribution, meeting the standards for human vaccines. Advanced inactivation technology, with a small amount of formaldehyde inactivation agent, reduces irritation to the body.
5. Antigen concentration, good immune effect
Adopting ultrafiltration concentration technology to ensure the high titer of Newcastle disease, adenovirus, and avian influenza H9 subtypes in each feather, high antibody titers are produced after immunization, and antibody production is fast. The antibody level significantly increases 7 days after immunization.